HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 82 filers reported holding HOMOLOGY MEDICINES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,106 | +32.2% | 1,800 | 0.0% | 0.00% | – |
| Q2 2023 | $1,593 | -14.1% | 1,800 | 0.0% | 0.00% | – |
| Q1 2023 | $1,854 | -18.3% | 1,800 | 0.0% | 0.00% | – |
| Q4 2022 | $2,268 | -24.4% | 1,800 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | -25.0% | 1,800 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -77.8% | 1,800 | -69.4% | 0.00% | – |
| Q1 2022 | $18,000 | +20.0% | 5,888 | +39.0% | 0.00% | – |
| Q4 2021 | $15,000 | -31.8% | 4,235 | +51.1% | 0.00% | – |
| Q3 2021 | $22,000 | +10.0% | 2,802 | +1.3% | 0.00% | – |
| Q2 2021 | $20,000 | 0.0% | 2,766 | +30.8% | 0.00% | – |
| Q1 2021 | $20,000 | +42.9% | 2,115 | +74.1% | 0.00% | – |
| Q4 2020 | $14,000 | +40.0% | 1,215 | +35.0% | 0.00% | – |
| Q3 2020 | $10,000 | 0.0% | 900 | +35.5% | 0.00% | – |
| Q2 2020 | $10,000 | +11.1% | 664 | +10.7% | 0.00% | – |
| Q1 2020 | $9,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,535,919 | $16,511,000 | 3.10% |
| Vida Ventures Advisors, LLC | 770,845 | $2,806,000 | 1.05% |
| Vivo Capital, LLC | 853,143 | $3,105,000 | 0.19% |
| AAF Wealth Management, LLC | 47,501 | $173,000 | 0.12% |
| OUP Management Co., LLC | 64,000 | $233,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 195,596 | $712,000 | 0.09% |
| Temasek Holdings (Private) Ltd | 5,650,996 | $20,570,000 | 0.07% |
| Bellevue Group AG | 1,737,122 | $6,323,000 | 0.06% |
| XTX Topco Ltd | 26,212 | $95,000 | 0.05% |
| Virtus ETF Advisers LLC | 37,588 | $137,000 | 0.05% |